Multi-institutional melanoma lymphatic mapping experience: The prognostic value of sentinel lymph node status in 612 stage I or II melanoma patients

Journal of Clinical Oncology

Volumn 17, Issue 3, 1999, Pages 976-983

  Gershenwald, Jeffrey E ^a   Thompson, William ^a   Mansfield, Paul F ^a   Lee, Jeffrey E ^a   Colome, Maria I ^a   Tseng, Chi Hong ^a   Lee, J Jack ^a   Balch, Charles M ^a   Reintgen, Douglas S ^a   Ross, Merrick I ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DISULFINE BLUE; HUMAN SERUM ALBUMIN TC 99M; TECHNETIUM SULFUR COLLOID TC 99M;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CHILD; DIAGNOSTIC ACCURACY; FEMALE; HUMAN; INTRADERMAL DRUG ADMINISTRATION; LYMPH NODE BIOPSY; LYMPH NODE METASTASIS; LYMPHADENECTOMY; LYMPHOSCINTIGRAPHY; MAJOR CLINICAL STUDY; MALE; MELANOMA; PRIORITY JOURNAL; PROGNOSIS;

EID: 0032977814     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/jco.1999.17.3.976     Document Type: Article

References (28)

1. Landis SH, Murray T, Bolden S, et al: Cancer statistics, 1998. CA Cancer J Clin 48:6-29, 1998
2. Silverberg E, Lubera JA: Cancer statistics, 1989. CA Cancer J Clin 39:3-20, 1989
3. Balch CM, Soong S-J, Milton GW, et al: A comparison of prognostic factors and surgical results in 1,786 patients with localized (stage I) melanoma treated in Alabama, USA, and New South Wales, Australia. Ann Surg 196:677-684, 1982
4. Drepper H, Kohler CO, Bastian B, et al: Benefit of elective lymph node dissection in subgroups of melanoma patients. Cancer 72:741-749, 1993
5. McCarthy WH, Shaw HM, Milton GW: Efficacy of elective lymph node dissection in 2,347 patients with clinical stage I malignant melanoma. Surg Gynecol Obstet 161:575-580, 1985
6. Rompel R, Garbe C, Buttner P, et al: Elective lymph node dissection in primary malignant melanoma: A matched-pair analysis. Melanoma Res 5:189-194, 1995
7. Wanebo HJ, Woodruff J, Fortner JG: Malignant melanoma of the extremities: A clinicopathologic study using levels of invasion (microstage). Cancer 35:666-676, 1975
8. Reintgen DS, Cox EB, McCarty KS Jr, et al: Efficacy of elective lymph node dissection in patients with intermediate thickness primary melanoma. Ann Surg 198:379-385, 1983
9. Balch CM, Soong S-J, Bartolucci AA, et al: Efficacy of an elective regional lymph node dissection of 1 to 4 mm thick melanomas for patients 60 years of age and younger. Ann Surg 224:255-266, 1996
10. Veronesi U, Adamus J, Bandiera DC, et al: Inefficacy of immediate node dissection in stage I melanoma of the limbs. N Engl J Med 297:627-630, 1977
11. Sim FH, Taylor WF, Pritchard DJ, et al: Lymphadenectomy in the management of stage I malignant melanoma: A prospective randomized study. Mayo Clin Proc 61:697-705, 1986
12. Morton DL, Wen D-R, Wong JH, et al: Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg 127:392-399, 1992
13. Reintgen D, Cruse CW, Berman C, et al: The orderly progression of melanoma nodal metastases. Ann Surg 220:759-767, 1994
14. Albertini JJ, Cruse CW, Rapaport D, et al: Intraoperative radiolymphoscintigraphy improves sentinel lymph node identification for patients with melanoma. Ann Surg 223:217-224, 1996
15. Thompson JF, McCarthy WH, Bosch CMJ, et al: Sentinel lymph node status as an indicator of the presence of metastatic melanoma in regional lymph nodes. Melanoma Res 5:255-260, 1995
16. Gershenwald JE, Colome MI, Thompson W, et al: Patterns of recurrence following a negative sentinel lymph node biopsy in 243 patients with stage I or II melanoma. J Clin Oncol 16:2253-2260, 1998
17. Gershenwald JE, Tseng C-h, Thompson W, et al: Improved sentinel lymph node localization in primary melanoma patients with the use of radiolabeled colloid. Surgery 124:203-210, 1998
18. Krag DN, Meijer SJ, Weaver DL, et al: Minimal-access surgery for staging of melanoma. Arch Surg 130:654-658, 1995
19. Uren RF, Howman-Giles R, Thompson JF, et al: Lymphoscintigraphy to identify sentinel lymph nodes in patients with melanoma. Melanoma Res 4:395-399, 1994
20. Balch CM, Urist MM, Karakousis CP, et al: Efficacy of 2-cm surgical margins for intermediate-thickness melanomas (1 to 4 mm): Results of a multi-institutional randomized surgical trial. Ann Surg 218:262-267, 1993
21. Veronesi U, Cascinelli N: Narrow excision (1-cm margin): A safe procedure for thin cutaneous melanoma. Arch Surg 126:438-441, 1991
22. Slingluff CL, Stidham KR, Ricci WM, et al: Surgical management of regional lymph nodes in patients with melanoma: Experience with 4682 patients. Ann Surg 219:120-130, 1994
23. McCarthy WH, Shaw HM, Thompson JF, et al: Time and frequency of recurrence of cutaneous stage I malignant melanoma with guidelines for follow-up study. Surg Gynecol Obstet 166:497-502, 1988
24. Soong S-J, Shaw HM, Balch CM, et al: Predicting survival and recurrence in localized melanoma: A multivariate approach. World J Surg 16:191-195, 1992
25. Cascinelli N, Morabito A, Santinami M, et al: Immediate or delayed dissection of regional nodes in patients with melanoma of the trunk: A randomized trial - WHO Melanoma Programme. Lancet 14:793-796, 1998
26. Kirkwood JM, Strawderman MH, Ernstoff MS, et al: Interferon alfa-2b adjuvant therapy of high-risk resected cutaneous melanoma: The Eastern Cooperative Oncology Group Trial EST 1684. J Clin Oncol 14:7-17, 1996
27. Grob JJ, Dreno B, de la Salmoniere P, et al: Randomised trial of interferon alfa-2a as adjuvant therapy in resected primary melanoma thicker than 1.5 mm without clinically detectable node metastases: French Cooperative Group on Melanoma. Lancet 351:1905-1910, 1998
28. Pehamberger H, Soyer HP, Steiner A, et al: Adjuvant interferon alfa-2a treatment in resected primary stage II cutaneous melanoma: Austrian Malignant Melanoma Cooperative Group. J Clin Oncol 16:1425-1429, 1998